By Editor , 15 October 2026
NEJM Trial: CGMs Add 5 Hours Daily in Target Range for Type 2 Patients

Aurora – October 14, 2026 -- Adults with type 2 diabetes who do not take insulin spent about five more hours per day within their target blood sugar range when using continuous glucose monitors (CGMs) than patients receiving routine care, according to a randomized trial published in the New England Journal of Medicine.

Nearly twice as many CGM users reached an A1c below 7%, a common treatment goal. The A1c gap between the two groups was 0.9 percentage points, which the researchers say greatly exceeds the threshold generally considered clinically meaningful.

By Editor , 15 October 2026
Worldwide Fistula Fund, Terrewode Merge as Maternal Dignity Project

Bend, Oregon – – October 14, 2026 -- Worldwide Fistula Fund and Terrewode Women's Fund have merged into Maternal Dignity Project, a U.S.-based nonprofit that will fund African-led organizations treating and preventing obstetric fistula in five countries.

By Editor , 15 October 2026
Vanda's VQW-765 Fails Phase III Social Anxiety Trial; Program on Hold

Washington – October 14, 2026 -- Vanda Pharmaceuticals (Nasdaq: VNDA) has put its VQW-765 program on hold after the Phase III Study 3201 in adults with social anxiety disorder missed its primary endpoint, and the company said the data did not confirm earlier Phase II findings.

By Editor , 15 October 2026
Colossal's GenoMorph AI flags 2,300 dodo beak-linked DNA targets

Dallas – October 14, 2026 -- Colossal Biosciences has unveiled GenoMorph, an in-house AI platform that identified an estimated 2,300 candidate regulatory DNA elements linked to avian beak size and shape, giving its dodo de-extinction program a prioritized list of targets for experimental testing.

By Editor , 15 October 2026
ASA Forms Advisory Committee of Seven Dermatology Leaders

New York – October 14, 2026 -- The American Skin Association (ASA), which has awarded more than $50 million in research grants, has formed a seven-member Emerging Dermatology Leaders Advisory Committee to guide its research priorities, pipeline therapy focus and patient education programs.

By Editor , 15 October 2026
Aurora Board Rejects Revised Curaleaf Bid, Opens Strategic Review

Edmonton – October 14, 2026 -- Aurora Cannabis' board unanimously recommended that shareholders reject Curaleaf Holdings' revised hostile offer, which remains open until December 4, 2026, and said its special committee is actively exploring alternatives, including a deal with one or more third parties.

By Editor , 15 October 2026
Owens & Minor Launches ARMOR-FLEX Wrap in Halyard Portfolio

Richmond, Va. – October 14, 2026 -- Owens & Minor has launched ARMOR-FLEX* Sterilization Wrap, a heavyweight wrap developed in-house and made in Lexington, N.C., that the company says is stronger, more flexible and more bacteria-resistant than traditional heavyweight wraps without adding weight.

The product joins the Halyard® portfolio and targets sterility breaches that can compromise patient safety and cause delays in the operating room.

By Editor , 15 October 2026
Medsender Passes 100 ModMed EMA Practices in 16 Months

NEW YORK – October 14, 2026 -- More than 100 specialty practices running ModMed EMA now use Medsender to manage incoming referrals, 16 months after the fax and referral management platform launched its EMA integration.

By Editor , 15 October 2026
MinuteClinic Wins 7th Joint Commission Accreditation, Adds Primary Care

Woonsocket – October 14, 2026 -- CVS Health's MinuteClinic has earned its seventh consecutive Joint Commission Ambulatory Health Care Accreditation, covering more than 800 locations nationwide and MinuteClinic Virtual Care, and for the first time the survey assessed its primary care sites under Medical Center standards.

By Editor , 15 October 2026
WIN Adds Growth, People and AI Chiefs as It Nears 1M Families

Greenwich – October 14, 2026 -- WIN, a fertility and family support benefit company, has appointed three senior leaders to newly created roles as its supported population grows from more than 500,000 to nearly one million families over two years.